drugset / Trial / NCT00611143

Atorvastatin for Prevention of Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting Surgery

NCT00611143 ↗

Completed 124 enrolled Samsung Medical Center
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether pretreatment with atorvastatin protects against atrial fibrillation following off-pump coronary artery bypass graft surgery.

Timeline

Start
2006-05
Primary completion
2007-04
Completion
2007-05

Outcome

Met primary endpoint

paper The incidence of AF was significantly lower in the atorvastatin group than in the control group (13% vs 27%, P = .04). PMID 18657672 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 20 mg —